Previous studies have focused on the transactivity effects of p53 through ASPP2 in the nucleus, while accumulating evidence has highlighted the tumor-suppressive role of ASPP2 crosstalk with other pathways35,38. This evidence concerns the gene TP53BP2 and neoplasm.